Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT
Conditions
- Chronic Myeloid Leukemia
- Acute Myelogenous Leukemia
- Myelodysplasia
- Acute Lymphocytic Leukemia
- Severe Aplastic Anemia
- Non-Hodgkin's Lymphoma
- Lymphoproliferative Disease
- Multiple Myeloma
- Advanced Myeloproliferative Disease
Interventions
- DRUG: Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF
Sponsor
University of California, San Francisco